Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04965493
Title A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (BRUIN CLL-322)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Loxo Oncology, Inc.
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Rituximab + Venetoclax

LOXO-305 + Rituximab + Venetoclax

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.